CD82 and ovarian carcinoma: Because we previously identified for the first time integrin αvß3 as a novel interaction partner of KAI1 in human ovarian cancer cells, besides ß1-integrins, we studied KAI1-WT/KAI1-SP effects on αvß3 expression levels.